查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561639

2024-2032 年按组件（3D 生物列印机、支架、生物材料）、应用（研究、临床）、最终用户（医院、研究组织和学术机构、生物製药公司）和地区分類的 3D 生物列印市场报告

3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球3D生物列印市场规模达12.058IMARC Group美元。不断增长的老年人口、对研发 (R&D) 活动的日益关注以及市场干扰的减少是推动市场成长的一些关键因素。

3D生物列印市场分析：

  • 主要市场驱动因素：3D生物列印在个人化医疗中的使用不断增加，主要推动了市场的成长。 3D生物列印可以创建患者特定的组织和器官，从而实现个人化治疗计划并降低移植排斥的风险。
  • 主要市场趋势：越来越多地利用生物列印来製造具有精确几何形状和生物功能的复杂生物医学设备和植入物，是推动市场成长的重要趋势之一。此外，3D生物列印技术的快速进步，包括改进的生物材料和列印技术，也有助于市场的扩张。
  • 竞争格局：全球市场上的一些领先参与者包括 3D Systems Inc.、Aspect Biosystems Ltd.、Cellink、Cyfuse Biomedical KK、EnvisionTEC GmbH (Desktop Metal Inc.)、GeSiM - Gesellschaftfur Silizium-Mikrosysteme mbH、Material Incise、 Organovo Holdings .、Poietis、RegenHU 和Stratasys Ltd. 等。
  • 地理格局：报告显示，北美（美国和加拿大）是生物3D列印的最大市场。推动北美 3D 生物列印市场的一些因素包括各种慢性疾病的日益普及、主要参与者的广泛存在以及私人和政府投资的增加。
  • 挑战与机会：全球3D生物列印市场面临成本高、技术复杂与监管障碍等挑战。然而，它提供了透过创新的组织工程解决方案来推进个人化医疗、提高药物测试准确性和解决器官移植短缺的机会。

3D生物列印市场趋势：

加强药物测试和开发

3D生物列印机对于药物测试和临床试验应用非常重要。预计它们将大大减少动物试验的需要，从而在伦理上有利且具有成本效益。随着3D生物列印的出现，药物开发商可以透过在类人3D列印组织上测试新药，轻鬆识别与人体临床试验相关的併发症，从而减少后期失败造成的损失。此外，公司不断增加的研发投资进一步增加了对 3D 生物列印等创新技术的需求。例如，根据美国国会预算办公室公布的资料，2021年，全球製药业在研发上的支出接近2,000亿美元，而2019年为8,300万美元。的研发投资为17.42 亿美元，而2020 年为13.48 亿美元。大量投资将在未来几年推动3D 生物列印市场的规模。

技术进步

3D 生物列印技术的不断进步进一步为整个市场提供了利润丰厚的成长机会。此外，各个领先的市场参与者正在合作并建立伙伴关係，以开发更先进、更有效率的 3D 生物列印技术。例如，2024 年 6 月，先进的组织模拟技术公司 Ronawk 与 B9Creations 合作，利用 Ronawk 的 Bio-Blocks 开发并大量生产 3D 生物列印水凝胶。与迫使细胞进入人工环境的传统方法不同，Ronawk 的生物块重建了细胞自然形成组织的条件。这导致组织与人类和动物组织的天然结构和功能非常相似。同样，2022 年 9 月，印度科学研究所 (IISc) 宣布与瑞典生物列印解决方案公司 CELLINK 合作，向卓越中心 (CoE) 提供两到三台生物印表机，每台都使用不同的列印方式技术以自己的成本。此外，2022 年 12 月，CELLINK 和 IISc 在印度共同建立了班加罗尔开创性的 3D 生物列印卓越中心。 3D 生物列印领域的此类创新、合作和扩展预计将对预测期内的 3D 生物列印市场前景产生积极影响。

癌症研究中不断成长的产品应用

3D生物列印广泛用于创建逼真的肿瘤模型，这些模型密切模仿实际人类肿瘤的复杂性和微环境。这些生物列印模型使研究人员能够在受控环境下研究癌症进展、转移和肿瘤-基质相互作用。此外，全球癌症病例的不断增加进一步为整个市场提供了利润丰厚的成长机会。例如，国际癌症研究机构（IARC）估计，2020年约有1929万名癌症病例。预计到 2030 年，这些病例将增加到 2,458 万例。除此之外，肺癌和乳癌是个体中最常见的两种癌症。加拿大癌症协会（CCS）表示，2020年，近29,800名加拿大人被诊断出罹患肺癌，占所有新发癌症病例的13%。预计约有21,200 名加拿大人死于肺癌，占2020 年所有癌症死亡人数的25%。药物机制并个性化客製化治疗方案。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球 3D 生物列印市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按组成部分

  • 3D生物列印机
    • 市场趋势
    • 关键环节
      • 注射器/挤出生物列印
      • 喷墨生物列印
      • 磁浮生物列印
      • 雷射辅助生物列印
      • 其他的
    • 市场预测
  • 鹰架
    • 市场趋势
    • 市场预测
  • 生物材料
    • 市场趋势
    • 关键环节
      • 活细胞
      • 水凝胶
      • 细胞外基质
      • 其他的
    • 市场预测

第 7 章：市场区隔：按应用

  • 研究
    • 市场趋势
    • 关键环节
      • 药物研究
      • 再生医学
      • 3D 细胞培养
    • 市场预测
  • 临床
    • 市场趋势
    • 关键环节
      • 皮肤
      • 骨骼和软骨
      • 血管
      • 其他的
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 研究机构及学术机构
    • 市场趋势
    • 市场预测
  • 生物製药公司
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3D Systems Inc.
    • Aspect Biosystems Ltd.
    • Cellink
    • Cyfuse Biomedical KK
    • EnvisionTEC GmbH (Desktop Metal Inc.)
    • GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
    • Materialise
    • Organovo Holdings Inc.
    • Poietis
    • RegenHU
    • Stratasys Ltd.
Product Code: SR112024A4556

The global 3D bioprinting market size reached US$ 1,205.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 4,281.9 Million by 2032, exhibiting a growth rate (CAGR) of 14.7% during 2024-2032. The growing geriatric population, increasing focus on research and development (R&D) activities, and less disrupted market represent some of the key factors driving the market growth.

3D Bioprinting Market Analysis:

  • Major Market Drivers: The increasing utilization of 3D bioprinting in personalized medicine is primarily driving the growth of the market. 3D bioprinting can create patient-specific tissues and organs, enabling personalized treatment plans and reducing the risk of transplant rejection.
  • Key Market Trends: The escalating utilization of bioprinting to manufacture complex biomedical devices and implants with precise geometries and biological functionalities is one of the significant trends driving the growth of the market. Furthermore, rapid advancements in 3D bioprinting technology, including improved biomaterials and printing techniques, are also contributing to the market expansion.
  • Competitive Landscape: Some of the leading players operating in the global market include 3D Systems Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU, and Stratasys Ltd., among others.
  • Geographical Landscape: According to the report, North America (the United States and Canada) was the largest market for 3D bioprinting. Some of the factors driving the North American 3D bioprinting market include the growing prevalence of various chronic diseases, the wide presence of key players, and increasing private and government investment.
  • Challenges and Opportunities: The global 3D bioprinting market faces challenges such as high costs, technical complexities, and regulatory hurdles. However, it presents opportunities to advance personalized medicine, improve drug testing accuracy, and address organ transplant shortages through innovative tissue engineering solutions.

3D Bioprinting Market Trends:

Increasing Drug Testing and Development

3D bioprinters are highly important for drug testing and clinical trial applications. They are expected to drastically reduce the need for animal trials, thus being ethically beneficial and cost-effective. With the advent of 3D bioprinting, drug developers can easily identify complications associated with human clinical trials by testing new drugs on human-like 3D-printed tissues, thereby reducing losses from late-stage failures. Additionally, the increasing investment in research and development by the companies is further escalating the demand for innovative technologies like 3D bioprinting. For instance, according to the data published by the Congressional Budget Office, in 2021, it has been observed that pharmaceutical industries spent nearly US$ 200 Billion on research and development in 2020 globally compared to US$ 83 Million in 2019. Similarly, Danaher Corporation invested US$ 1,742 Million in its research and development in 2021, as compared to US$ 1,348 Million in 2020. In addition, Bio-Rad Laboratories Inc. invested US$ 879.6 Million in 2021 as compared to US$ 800.3 Million in 2020. Such significant investments in drug trials and drug development are anticipated to propel the 3D bioprinting market size in the coming years.

Technological Advancements

Ongoing technological advancements in 3D bioprinting are further offering lucrative growth opportunities to the overall market. Additionally, various leading market players are collaborating and forming partnerships to develop more advanced and efficient 3D bioprinting technologies. For instance, in June 2024, advanced tissue mimetic technologies company Ronawk partnered with B9Creations to develop and mass-produce 3D bioprinted hydrogels leveraging Ronawk's Bio-Blocks. Unlike traditional methods that force cells into artificial environments, Ronawk's Bio-Blocks recreate conditions that allow cells to form tissues naturally. This results in tissue that closely resembles the native architecture and function of human and animal tissues. Similarly, in September 2022, the Indian Institute of Science (IISc) announced its collaboration with CELLINK, a Sweden-based bioprinting solutions company, to provide two to three bioprinters to the Centre of Excellence (CoE), each of which uses a different printing technology at its own cost. Additionally, in December 2022, CELLINK and IISc jointly established Bengaluru's pioneering 3D Bioprinting Centre of Excellence in India. Such innovations, collaborations, and expansion in 3D bioprinting are projected to positively impact the 3D bioprinting market outlook over the forecasted period.

Growing Product Application in Cancer Research

3D bioprinting is widely used in the creation of realistic tumor models that closely mimic the complexity and microenvironment of actual human tumors. These bioprinted models enable researchers to study cancer progression, metastasis, and tumor-stroma interactions in a controlled setting. Moreover, the escalating cases of cancer across the globe are further offering lucrative growth opportunities to the overall market. For instance, the International Agency for Research on Cancer (IARC) estimated that, in the year 2020, there were about 19.29 million cancer cases. These cases are projected to increase to 24.58 million cases by 2030. Additionally, according to GLOBOCAN, in 2020, there were approximately 2,281,658 new cancer cases diagnosed and 612,390 deaths due to cancer alone in the United States. In addition to this, lung cancer and breast cancer are two of the most common cancers found among individuals. The Canadian Cancer Society (CCS) stated that in 2020, nearly 29,800 Canadians were diagnosed with lung cancer, which accounted for 13% of all new cancer cases. About 21,200 Canadians were expected to die from lung cancer, which represented 25% of all cancer deaths in 2020. Such a substantial growth in cancer cases is augmenting the demand for 3D bioprinting technologies that help identify effective treatments, understand drug resistance mechanisms, and personalize cancer therapies.

Global 3D Bioprinting Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global 3D bioprinting market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on component, application, and end user.

Component Insights:

  • 3D Bioprinters
    • Syringe/Extrusion Bioprinting
    • Inkjet Bioprinting
    • Magnetic Levitation Bioprinting
    • Laser-assisted Bioprinting
    • Others
  • Scaffolds
  • Biomaterials
    • Living Cells
    • Hydrogels
    • Extracellular Matrices
    • Others

3D bioprinters (syringe/extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others) represented the largest segment

The 3D bioprinting market research report has provided a detailed breakup and analysis of the 3D bioprinting market based on the component. This includes 3D bioprinters (syringe/extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others), scaffolds, and biomaterials (living cells, hydrogels, extracellular matrices, and others). According to the report, 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others) represented the largest segment.

The bolstering demand for 3D bioprinters can be attributed to the increasing utilization of syringe or extrusion-based bioprinting technology in printing various biological compounds or devices. They are widely used in fabricating tissue scaffolds for regenerative medicine, developing organ models for transplant research, and creating realistic tissue models for drug testing and cancer research. Moreover, 3D bioprinters have the ability to produce complex, customized biological structures, improve the accuracy of drug testing, and reduce the need for animal testing. As a result, they are widely used in the fields of tissue engineering, personalized medicine, pharmaceutical development, and medical research.

Application Insights:

  • Research
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical
    • Skin
    • Bone and Cartilage
    • Blood Vessels
    • Others

Research (drug research, regenerative medicine, and 3D cell culture) accounted for the largest market share

A detailed breakup and analysis of the 3D bioprinting market based on the application has also been provided in the report. This includes research (drug research, regenerative medicine, and 3D cell culture) and clinical (skin, bone and cartilage, blood vessels, and others). According to the report, research (drug research, regenerative medicine, and 3D cell culture) accounted for the largest market share.

The growth of this segment can be attributed to the widespread utilization of 3D printing technology among researchers to study the effects of different diseases and their progression and possible treatments. Moreover, it reduces the need to use lab animals for medical tests and dangerous trials on humans. Additionally, the 3D bioprinting market forecast by IMARC indicates that the increasing drug development and drug trial activities are bolstering the application of 3D bioprinting in research. For instance, with the COVID-19 pandemic behind, the US Food and Drug Administration (FDA) approved 55 new drugs in 2023, a figure consistent with the number authorized in the last five years (53 per year on average). Thus, 2023 marks the second-best yearly FDA harvest after 2018 (59 approvals) in all the series. Such a significant growth in drug trials and approval is creating a positive outlook for the overall market.

End User Insights:

  • Hospitals
  • Research Organization and Academic Institutes
  • Biopharmaceuticals Companies

Biopharmaceuticals companies accounted for the largest market share

A detailed breakup and analysis of the 3D bioprinting market based on the end user has also been provided in the report. This includes hospitals, research organization and academic institutes, and biopharmaceuticals companies. According to the report, biopharmaceuticals companies accounted for the largest market share.

The 3D bioprinting market statistics by IMARC indicate that the increasing number of target therapies is primarily driving the growth of this segment. In addition to this, the rising collaborations and mergers and acquisition activities among biopharmaceutical companies to develop 3D bioprinting are positively influencing the market. For instance, in June 2022, REGEMAT 3D, a company at the forefront of personalized bio fabrication solutions, announced a partnership with Humabiologics, a company providing human-derived biomaterials for regenerative medicine, in response to the growing demand and to serve a broader life sciences customer base of the industry partners and academic institutions in the European bioprinting and drug testing market.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America (the United States and Canada) was the largest market for 3D bioprinting

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for 3D bioprinting.

Some of the factors driving the North American 3D bioprinting market included the growing prevalence of various chronic diseases, the presence of key players, and increasing private and government investments. Additionally, new product launches by the key market players in the region, along with the easy allocation of funds to conduct R&D activities, are further creating a positive outlook for the overall market. For instance, in 2022, scientists from Florida Atlantic University and the University of Virginia created a robotic model of the human spine to assist surgeons in anticipating the outcomes of interventions before surgery. Thus, the increasing demand for 3D bioprinting for healthcare physicians is expected to boost the market over the forecast period. Additionally, the rising investments by the regional government authorities in the healthcare sector are projected to propel the 3D bioprinting market share in the coming years.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global 3D bioprinting market. Some of the companies covered in the report include:

  • 3D Systems Inc.
  • Aspect Biosystems Ltd.
  • Cellink
  • Cyfuse Biomedical K.K.
  • EnvisionTEC GmbH (Desktop Metal Inc.)
  • GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
  • Materialise
  • Organovo Holdings Inc.
  • Poietis
  • RegenHU
  • Stratasys Ltd.

(Please note that this only represents a partial list of companies, and the complete list has been provided in the report.)

Global 3D Bioprinting Market News:

  • June 2024: Advanced tissue mimetic technologies company Ronawk partnered with B9Creations to develop and mass-produce 3D bio-printed hydrogels leveraging Ronawk's Bio-Blocks.
  • February 2024: Nanavati Max Super Specialty Hospital in Mumbai, India, launched a medical 3D printing laboratory to facilitate high-precision surgeries. The facility is closely integrated with oncology to enable state-of-the-art surgeries that need to be performed carefully and accurately in oncologic, reconstructive orthopedic, and specialized dentistry surgeries. The 3D printing laboratory features two 3D printers capable of producing bone models for a better understanding of intricate anatomy or pathology.

Key Questions Answered in This Report

  • 1. What was the size of the global 3D bioprinting market in 2023?
  • 2. What is the expected growth rate of the global 3D bioprinting market during 2024-2032?
  • 3. What are the key factors driving the global 3D bioprinting market?
  • 4. What has been the impact of COVID-19 on the global 3D bioprinting market?
  • 5. What is the breakup of the global 3D bioprinting market based on the component?
  • 6. What is the breakup of the global 3D bioprinting market based on the application?
  • 7. What is the breakup of the global 3D bioprinting market based on the end user?
  • 8. What are the key regions in the global 3D bioprinting market?
  • 9. Who are the key players/companies in the global 3D bioprinting market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global 3D Bioprinting Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 3D Bioprinters
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Syringe/Extrusion Bioprinting
      • 6.1.2.2 Inkjet Bioprinting
      • 6.1.2.3 Magnetic Levitation Bioprinting
      • 6.1.2.4 Laser-assisted Bioprinting
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Scaffolds
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biomaterials
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Living Cells
      • 6.3.2.2 Hydrogels
      • 6.3.2.3 Extracellular Matrices
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Research
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Drug Research
      • 7.1.2.2 Regenerative Medicine
      • 7.1.2.3 3D Cell Culture
    • 7.1.3 Market Forecast
  • 7.2 Clinical
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Skin
      • 7.2.2.2 Bone and Cartilage
      • 7.2.2.3 Blood Vessels
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Organization and Academic Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Biopharmaceuticals Companies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3D Systems Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Aspect Biosystems Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cellink
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Cyfuse Biomedical K.K.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 EnvisionTEC GmbH (Desktop Metal Inc.)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Materialise
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Organovo Holdings Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Poietis
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 RegenHU
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stratasys Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: 3D Bioprinting Market: Major Drivers and Challenges
  • Figure 2: Global: 3D Bioprinting Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: 3D Bioprinting Market: Breakup by Component (in %), 2023
  • Figure 5: Global: 3D Bioprinting Market: Breakup by Application (in %), 2023
  • Figure 6: Global: 3D Bioprinting Market: Breakup by End User (in %), 2023
  • Figure 7: Global: 3D Bioprinting Market: Breakup by Region (in %), 2023
  • Figure 8: Global: 3D Bioprinting (3D Bioprinters) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: 3D Bioprinting (3D Bioprinters) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: 3D Bioprinting (Scaffolds) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: 3D Bioprinting (Scaffolds) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: 3D Bioprinting (Biomaterials) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: 3D Bioprinting (Biomaterials) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: 3D Bioprinting (Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: 3D Bioprinting (Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: 3D Bioprinting (Clinical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: 3D Bioprinting (Clinical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: 3D Bioprinting (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: 3D Bioprinting (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: United States: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: United States: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Canada: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Canada: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Asia-Pacific: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Asia-Pacific: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: China: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: China: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Japan: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Japan: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: India: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: India: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: South Korea: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: South Korea: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Australia: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Australia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Indonesia: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Indonesia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Europe: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Europe: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Germany: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Germany: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: France: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: France: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United Kingdom: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United Kingdom: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Italy: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Italy: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Spain: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Spain: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Russia: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Russia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Latin America: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Latin America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Brazil: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Brazil: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Mexico: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Mexico: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Middle East and Africa: 3D Bioprinting Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Middle East and Africa: 3D Bioprinting Market: Breakup by Country (in %), 2023
  • Figure 72: Middle East and Africa: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Global: 3D Bioprinting Industry: SWOT Analysis
  • Figure 74: Global: 3D Bioprinting Industry: Value Chain Analysis
  • Figure 75: Global: 3D Bioprinting Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: 3D Bioprinting Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: 3D Bioprinting Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: 3D Bioprinting Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: 3D Bioprinting Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: 3D Bioprinting Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: 3D Bioprinting Market: Competitive Structure
  • Table 7: Global: 3D Bioprinting Market: Key Players